HeartCore to appeal Nasdaq delisting; preliminary Q3 revenue up 263-305% YoY

HeartCore Enterprises, Inc.

Received Nasdaq notice on Oct 22, 2024 for non-compliance with $1 minimum bid price; trading suspended Oct 31 if no appeal.
Intends to timely appeal; hearing request will stay suspension pending Panel decision.
Preliminary Q3 2024 revenue $17-19M (YoY +263-305%); net income $9-11M.
Prior compliance period expired Oct 21, 2024; company had been granted additional 180 days in April 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.